Double Medical Technology Inc. (SHE:002901)
China
· Delayed Price · Currency is CNY 33.94
-1.44 (-4.07%)
Apr 24, 2025, 3:04 PM CST
Double Medical Technology Revenue
In the year 2024, Double Medical Technology had annual revenue of 2.14B CNY with 39.29% growth. Double Medical Technology had revenue of 606.30M in the quarter ending December 31, 2024, with 48.72% growth.
Revenue
2.14B
Revenue Growth
+39.29%
P/S Ratio
6.48
Revenue / Employee
529.52K
Employees
4,033
Market Cap
13.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.14B | 602.44M | 39.29% |
| Dec 31, 2023 | 1.53B | 99.02M | 6.90% |
| Dec 31, 2022 | 1.43B | -560.23M | -28.09% |
| Jan 1, 2022 | 1.99B | 407.47M | 25.68% |
| Dec 31, 2020 | 1.59B | 329.54M | 26.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |